Commonly Used Medications and Breast Cancer Recurrence

Contact: Denise Boudreau, Ph.D.

Number of Enrolled Cancer Patients/Survivors: 4,400
Years of Diagnoses of Enrolled Cancer Patients/Survivors: 1990-2008
Approximate Years of Follow-up: Median of 10 years (max. 18)
Cancer Sites Represented: Breast
Biological Specimens Collected: None
Treatment Outcome Measures: Physician/Medical Record Reported
  • Cancer Recurrence
  • Death
  • Other
Co-morbidities at Study Entry: Diabetes
Heart Disease
Pulmonary Disease
Other: Automated data on all co-morbidities during year prior to and during years following breast cancer diagnosis
Lifestyle Factors: Smoking
Body Mass Index
Weight Loss/Control
Treatment Data: Surgery
Hormonal Therapy
Bone Marrow/Stem Cell Transplant
Treatment Data Assessed By: Administrative Claims Data
Electronic Record
Chart Abstraction
Other: All medication dispensings per health plan records, self-reported side effects and reasons for discontinuing hormone therapy, tumor characteristics per SEER, second primaries, SEER link to other cancers, sociodemographics (race, education, geocoded data), screening, and surveillance history.
Is the study open to collaboration? Yes

Return to Top